Cargando…

Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure

AIMS: Cardiac amyloidosis (CA) is an under‐diagnosed cause of heart failure (HF) and has a worse prognosis than other forms of HF. The frequency of death or rehospitalization following discharge for acute heart failure (AHF) in CA (relative to other causes) has not been documented. The study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berthelot, Emmanuelle, Broussier, Amaury, Hittinger, Luc, Donadio, Cristiano, Rovani, Xavier, Salengro, Emmanuel, Megbemado, Richard, Godreuil, Christian, Belmin, Joel, David, Jean Philippe, Genet, Bastien, Damy, Thibaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192232/ https://www.ncbi.nlm.nih.gov/pubmed/37051755 http://dx.doi.org/10.1002/ehf2.14337

Ejemplares similares

Good performance in the management of acute heart failure in cardiogeriatric departments: the ICREX-94 experience
por: Berthelot, Emmanuelle, et al.
Publicado: (2021)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2023)

Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild‐type cardiac amyloidosis
por: Kharoubi, Mounira, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on the burden of chronic heart failure patients in France
por: Berthelot, Emmanuelle, et al.
Publicado: (2021)

Prevalence and determinants of iron deficiency in cardiac amyloidosis
por: Jobbé‐Duval, Antoine, et al.
Publicado: (2022)

Usefulness of 99mTc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis
por: Galat, Arnault, et al.
Publicado: (2015)

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis – Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
por: Kristen, Arnt V., et al.
Publicado: (2017)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature
por: Adam, Robert Daniel, et al.
Publicado: (2021)

Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
por: Aouate, David, et al.
Publicado: (2020)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

History of extracardiac/cardiac events in cardiac amyloidosis: prevalence and time from initial onset to diagnosis
por: Kharoubi, Mounira, et al.
Publicado: (2021)

Asymptomatic COVID-19 cases among older patients despite BNT162b2 vaccination: A case series in a geriatric rehabilitation ward during an outbreak
por: Donadio, Cristiano, et al.
Publicado: (2021)

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Transthyretin cardiac amyloidosis in Saudi Arabia and the Middle East: insights, projected prevalence and practical applications
por: Mohty, Dania, et al.
Publicado: (2023)

Investigation of an Outbreak of COVID-19 in a French Nursing Home With Most Residents Vaccinated
por: Burugorri-Pierre, Catherine, et al.
Publicado: (2021)

Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism
por: Damy, Thibaud, et al.
Publicado: (2011)

Left ventricular and atrial function in systemic light chains amyloidosis: an echocardiography and cardiac magnetic resonance comparison
por: Mohty, Dania, et al.
Publicado: (2015)

DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis
por: Akinboboye, Olakunle, et al.
Publicado: (2015)

Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants
por: Touboul, Olivier, et al.
Publicado: (2022)

Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy
por: Quarta, C. Cristina, et al.
Publicado: (2022)

Echocardiographic Patterns of Left Ventricular Diastolic Function in Cardiac Amyloidosis: An Updated Evaluation
por: Oghina, Silvia, et al.
Publicado: (2021)

Glutathione Deficiency in Cardiac Patients Is Related to the Functional Status and Structural Cardiac Abnormalities
por: Damy, Thibaud, et al.
Publicado: (2009)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Heart Transplantation, Either Alone or Combined With Liver and Kidney, a Viable Treatment Option for Selected Patients With Severe Cardiac Amyloidosis
por: Guendouz, Soulef, et al.
Publicado: (2022)

Prescription, Compliance, and Burden Associated with Salt-Restricted Diets in Heart Failure Patients: Results from the French National OFICSel Observatory
por: Damy, Thibaud, et al.
Publicado: (2022)

Digoxin in amyloidosis: Is it associated with a greater incidence of arrhythmogenic potential?
por: Ibrahim, Ramzi, et al.
Publicado: (2022)

Hospitalisation and life support in the year before and during heart transplantation: a French national study
por: Cantrelle, Christelle, et al.
Publicado: (2018)

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
por: Oghina, Silvia, et al.
Publicado: (2021)

Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement
por: Bézard, Mélanie, et al.
Publicado: (2021)

Cardiovascular outcomes after cardiac resynchronization therapy in cardiac amyloidosis
por: Fischer, Kilian, et al.
Publicado: (2021)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Coronavirus Disease 2019 Outcomes in French Nursing Homes That Implemented Staff Confinement With Residents
por: Belmin, Joël, et al.
Publicado: (2020)

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths
por: Li, Qing, et al.
Publicado: (2019)

Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study
por: Bodez, Diane, et al.
Publicado: (2016)

Le stress des cadres
por: Salengro, Bernard
Publicado: (2005)

Chronology of COVID-19 Symptoms in Very Old Patients: Study of a Hospital Outbreak
por: Lafuente-Lafuente, Carmelo, et al.
Publicado: (2021)

Amyloidosis and 30-Day Outcomes Among Patients With Heart Failure: A Nationwide Readmissions Database Study
por: Arora, Sameer, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_497qpee9n0i2k3q6f2g95searn